Enabling next-gen targeted biotherapeutics
The Athebody platform enables drug developers to create targeted biotherapeutics with unprecedented specificity, efficacy and safety profile.
Mission
We are here to explore and unleash the therapeutic potential of repeat proteins. We aim to make it accessible to drug developers.
Advanced Technology
Athebody platform
The versatile and ultra-stable Athebody® DARPin scaffold, paired with a highly efficient discovery engine, offers a diverse array of therapeutic candidates. These candidates boast excellent target affinity and specificity, high solubility across various buffer conditions, an outstanding manufacturing profile, and the ease of generating multi-specificity.
